跳至主要内容
临床试验/TCTR20200530002
TCTR20200530002尚未招募1 期

Reduction in interleukin-5 and other eosinophil biomarkers by full-house endoscopic sinus surgery in the treatment of severe nasal polyps

Department of Otolaryngology, Faculty of medicine, Chulalongkorn University0 个研究点目标入组 20 人开始时间: 2020年5月30日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • Any CRSwNP patient is defined as the presence of two or more symptoms for > 12 weeks, one of which should be:
  • either nasal blockage/obstruction/congestion or nasal discharge (anterior/posterior nasal drip)
  • ± facial pain/pressure
  • ± reduction or loss of smell
  • AND along with endoscopic and radiographic evidence of nasal polyps, grade ≥2 and diffuse bilateral mucosal inflammation
  • AND have indication for sinus surgery
  • **grade 0 being no visible polyps; grade 1 being polyps confined to the middle meatus; grade 2 being polyps beyond the middle meatus but not completely obstructing the nasal cavity; and grade 3 being polyps completely obstructing the nasal cavity

排除标准

  • 1. prior sinus surgery
  • 2. unilateral sinus changes
  • 3. sinus disease associated with systemic conditions
  • 4. under the age of 18
  • 5. pregnant women
  • 6. undertaking systemic and intranasal steroids and immunosuppressive medication during the past month

研究者

发起方
Department of Otolaryngology, Faculty of medicine, Chulalongkorn University

相似试验